- Home
- JBIO
JBIO
JADE BIOSCIENCES INC
as 07-02-2025 4:00pm EST
Stocks
| Founded: | 2024 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $15.50 | AVG Volume (30 days): | 674.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -18.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.57 - $13.50 | Next Earning Date: | 08-05-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest JADE BIOSCIENCES INC News
JBIO Breaking Stock News: Dive into JBIO Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
Barchart
9 days ago
2 Small-Cap Stocks Under $10 to Buy With Big Potential
GlobeNewswire
24 days ago
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
GlobeNewswire
a month ago
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
GlobeNewswire
2 months ago
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
2 months ago
Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
Share on Social Networks:
Disclaimer
The information presented on this page, "JBIO JADE BIOSCIENCES INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.